Appointment of advisors and establishment of the central list
Article 2
1. For the purpose of Article 106(5) of Regulation (EU) 2017/745, advisors shall be appointed to the expert panels following a call for expression of interest and consultation with the Medical Device Coordination Group (‘MDCG’), based on selection criteria stipulated in that call for expression of interest. 2. The number of members of each expert panel shall be determined in the call for expression of interest referred to in paragraph 1. 3. For the purpose of Article 106(6) of Regulation (EU) 2017/745 and following consultation with the MDCG, advisors who satisfy the criteria stipulated in the call but who are not appointed to an expert panel shall be included in a central list of available experts (the ‘central list’). 4. Advisors shall be selected with regard to the need to ensure: (a) adequate and up-to-date clinical, scientific or technical expertise in the areas referred to in Article 1(1); (b) independence, impartiality, objectivity and absence of conflict of interest as outlined in Article 107 of Regulation (EU) 2017/745; (c) balanced geographical representation. 5. Where it is necessary due to the workload of a certain expert panel or the need to provide the required expertise to a certain expert panel, additional advisors may be appointed to that expert panel from the central list. 6. Where it is necessary due to the workload of a certain expert panel or the need to provide the required expertise to a certain expert panel, advisors on the central list or in another expert panel may be assigned to that expert panel for specific tasks and for a limited period of time. 7. The central list may be updated by launching subsequent calls for expression of interest.